Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

Acral lentiginous melanoma (ALM) is one of the four major subtypes in cutaneous melanoma (CM). Although ALM has a poorer prognosis than other CM subtypes, the prognostic factors associated with ALM have only been verified in small‐sized cohorts because of the low incidence of ALM worldwide.

[1]  Shuangge Ma,et al.  Racial differences in six major subtypes of melanoma: descriptive epidemiology , 2016, BMC Cancer.

[2]  B. Dai,et al.  Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases , 2016, Scientific Reports.

[3]  M. Cuéllar-Hubbe,et al.  Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype , 2016, Annals of Surgical Oncology.

[4]  A. Minagawa,et al.  Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot. , 2016, The New England journal of medicine.

[5]  Johan Hansson,et al.  Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature , 2016, Clinical epidemiology.

[6]  A. Richetta,et al.  Is the prognosis and course of acral melanoma related to site-specific clinicopathological features? , 2016, European review for medical and pharmacological sciences.

[7]  S. Lourenço,et al.  MAP Kinase Pathways: Molecular Roads to Primary Acral Lentiginous Melanoma , 2015, The American Journal of dermatopathology.

[8]  Greta M. Massetti,et al.  Vital Signs: Melanoma Incidence and Mortality Trends and Projections — United States, 1982–2030 , 2015, MMWR. Morbidity and mortality weekly report.

[9]  O. Gefeller,et al.  443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011. , 2015, European journal of cancer.

[10]  K. Tsuta,et al.  BRAF V600 mutations and pathological features in Japanese melanoma patients , 2014, Melanoma research.

[11]  Junfeng Xia,et al.  Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2. , 2015, DNA and cell biology.

[12]  J. Malvehy,et al.  TERT gene amplification is associated with poor outcome in acral lentiginous melanoma. , 2014, Journal of the American Academy of Dermatology.

[13]  J. Coebergh,et al.  Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015 , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  G. Stamp,et al.  The mutational burden of acral melanoma revealed by whole‐genome sequencing and comparative analysis , 2014, Pigment cell & melanoma research.

[15]  E. Moreira,et al.  [Cutaneous malignant melanoma: a retrospective study of seven years (2006-2012)]. , 2014, Acta medica portuguesa.

[16]  J. Stein,et al.  Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines? , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[17]  Lei Wang,et al.  The association between trauma and melanoma in the Chinese population: a retrospective study , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  F. Boriani,et al.  Acral Lentiginous Melanoma - misdiagnosis, referral delay and 5 years specific survival according to site. , 2014, European review for medical and pharmacological sciences.

[19]  L. Kanter‐Lewensohn,et al.  KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. , 2013, Journal of dermatological science.

[20]  S. Kweon,et al.  A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. , 2013, JAMA dermatology.

[21]  D. Coit,et al.  Prognosis of Acral Melanoma: A Series of 281 Patients , 2013, Annals of Surgical Oncology.

[22]  C. Derancourt,et al.  Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review , 2012, The British journal of dermatology.

[23]  Suat Hoon Tan,et al.  Melanoma: differences between Asian and Caucasian patients. , 2012, Annals of the Academy of Medicine, Singapore.

[24]  Pragna Patel,et al.  Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. , 2011, Journal of the American Academy of Dermatology.

[25]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[26]  J. Q. Rosso,et al.  Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005 , 2010 .

[27]  P. Amerio,et al.  Epidemiology and clinical and pathologic characteristics of cutaneous malignant melanoma in Abruzzo (Italy) , 2009, International journal of dermatology.

[28]  T. Saida,et al.  Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update , 2008, International Journal of Clinical Oncology.

[29]  L. Thomas,et al.  Acral lentiginous melanoma: histopathological prognostic features of 121 cases , 2007, The British journal of dermatology.

[30]  L. Thomas,et al.  Acral lentiginous melanoma: a clinicoprognostic study of 126 cases , 2006, The British journal of dermatology.

[31]  T. Kuo,et al.  Malignant melanoma in Taiwan: a prognostic study of 181 cases , 2004, Melanoma research.

[32]  K. Wong,et al.  Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese , 2004, Clinical and experimental dermatology.

[33]  G. Giles,et al.  A case-control study of melanomas of the soles and palms (Australia and Scotland) , 1999, Cancer Causes & Control.

[34]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[35]  C. Garbe,et al.  Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients , 2000, The British journal of dermatology.

[36]  J. Grob,et al.  Delays in diagnosis and melanoma prognosis (I): The role of patients , 2000, International journal of cancer.

[37]  H. Tagami,et al.  Epidemiology and prognosis of subungual melanoma in 34 Japanese patients , 1996, The British journal of dermatology.

[38]  A. Testori,et al.  Acral lentiginous melanoma. A histological type without prognostic significance. , 1994, The Journal of dermatologic surgery and oncology.

[39]  J. Koea,et al.  Acral (volar‐subungual) melanoma in Auckland, New Zealand , 1988, The British journal of surgery.

[40]  W. P. Coleman,et al.  Acral lentiginous melanoma. , 1980, Archives of dermatology.